Demonstrates improved adhesion properties of hydroxyapatite-chitosan coatings on implants, highlighting potential for better performance in biomedicine.
The Ti6Al4V alloy is a common choice for biomedical implants due to its biocompatibility and corrosion resistance, though improvements are continually sought for long-term safety and performance. To address this, a hydroxyapatite (HAP), a bioceramic material structurally similar to bone, was utilized as coating agent. To enhance its properties, HAP was blended with chitosan (CS) to create a hydroxyapatite-chitosan (HAP/CS) nanocomposite coating. The Ti6Al4V alloy substrates were uniquely fabricated using laser powder bed fusion (LPBF) to mimic natural bone structure, and the HAP/CS coatings were deposited by electrophoretic deposition (EPD). The phase composition and microstructure were analyzed by X-ray diffraction (XRD) and scanning electron microscope (SEM), respectively. A scratch test was performed to evaluate the adhesion strength and durability. The integration of chitosan significantly improved the interfacial bond and cohesion of the coating. Specifically, the 30% CS/HAP coating exhibited the optimal adhesion performance, achieving a total delamination critical load (LC3) of 6.87 ± 0.34 N, a 28.4% increase compared to the pure HAP coating (5.35 ± 0.27 N). This study indicates that HAP/CS coatings can ameliorate Ti6Al4V performance and enhance the biocompatibility of implants for biomedical usage.
No takes yet. Share an insight, caveat, or question.
Kammoun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: